Search 25,000+ prices/
Medicine prices in Australia

Tildrakizumab Price in Australia (2026)

Compiled by the TrustClinix data team · Medical review pending3 official sourcesPrices last checked 25 October 2026How we get our data
Lowest PBS approved ex-manufacturer price
A$2,955

Cheapest pack: Ilumya, Injection 100 mg in 1 mL single dose pre-filled syringe, 1. Official PBS price list, Oct 2026.

≈ $2,075
A$2,955 – A$5,909
per pack
1
strength
2
listed products
PBS price
price type
What you actually pay

What a patient pays for tildrakizumab in Australia

A$2,955
official PBS price for Ilumya, 1
Up to A$25.00
you pay per prescription (general patient)
A$7.70
with a concession card

Most a general patient pays per PBS prescription (A$7.70 with a concession card). If the medicine costs the pharmacy less than this, you pay the lower dispensed price.

2 products

One product name across 1 strength are on the official list.

Every listed product

All 2 tildrakizumab products in Australia

Tildrakizumab official prices in Australia
ProductStrength and formPackPricePer unit
IlumyaInjection 100 mg in 1 mL single dose pre-filled syringe1A$2,955—
IlumyaInjection 100 mg in 1 mL single dose pre-filled syringe1A$5,909—
What this price means

How PBS prices work in Australia

Prices on this page are the approved ex-manufacturer price on the Pharmaceutical Benefits Scheme (PBS): what the Australian Government has agreed to pay the supplier for the pack. Pharmacy mark-up and dispensing fees are added on top. Patients with a PBS prescription do not pay this price; they pay a government-capped co-payment (lower for concession card holders), and the PBS covers the rest.

Read the full guide to medicine prices in Australia.

A–Z

Other medicine prices in Australia

Keep exploring

What people check next

Quick answers

Frequently asked questions

How much does tildrakizumab cost in Australia?
Official PBS prices for tildrakizumab in Australia range from A$2,955 to A$5,909 per pack across 2 listed products.
What kind of price is this?
It is the approved ex-manufacturer price on the Pharmaceutical Benefits Scheme (PBS): what the Australian Government has agreed to pay the supplier for the pack. Pharmacy mark-up and dispensing fees are added on top. Patients with a PBS prescription do not pay this price; they pay a government-capped co-payment (lower for concession card holders), and the PBS covers the rest.
How much will I pay for tildrakizumab at a pharmacy in Australia?
Up to A$25.00 for Ilumya (1). Most a general patient pays per PBS prescription (A$7.70 with a concession card). If the medicine costs the pharmacy less than this, you pay the lower dispensed price.
Evidence

Sources

  1. Australian Government Department of Health, Disability and Ageing. Pharmaceutical Benefits Scheme (PBS) Schedule, 1 October 2026 (PBS API). www.pbs.gov.au/. Retrieved 25 October 2026.
  2. Australian Government Department of Health, Disability and Ageing (PBS). PBS patient co-payments from 1 January 2026: general A$25.00, concessional A$7.70 per script; Safety Net A$1,748.20 / A$277.20. pbs.gov.au/about/what-is-the-pbs/what-are-the-current-patient-fees-and. Retrieved 25 October 2026.
  3. European Central Bank. Euro foreign exchange reference rates (2026-10-23). www.ecb.europa.eu/stats/eurofxref/eurofxref-daily.xml. Retrieved 25 October 2026.

Important: These are published reference prices and estimates, not a quote, and not medical advice. Actual costs depend on the hospital, your health, the exact treatment and your insurance. Always confirm the price with the provider before treatment. Read our disclaimer · Report an error